Celularity Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Celularity Inc. (CELU) on May 21, 2026. The filing addresses the resolution of a dispute with Helena Global Investment Opportunities 1 Ltd. ("Helena") regarding previously disclosed convertible preferred stock and a promissory note.
Key Financial Metrics and Obligations
The filing details a specific settlement agreement rather than standard periodic financial results. Key financial terms of the settlement include:
- Immediate Cash Payment: $500,000 payable to Helena.
- Deferred Payments: Five (5) consecutive monthly payments of $100,000 each.
- Debt Restructuring: Assignment of certain rights under a $2,500,000 promissory note.
- Equity Surrender: Helena surrendered its shares of Series A Convertible Preferred Stock.
The filing text does not provide clear values for total revenue, net profit, operating cash flow, or overall liquidity positions for the period.
Material Changes and Events
The primary material change is the entry into a Settlement Agreement to resolve claims arising from an event of default declared by Helena under a Convertible Promissory Note. This agreement restructures obligations under the Securities Purchase Agreement dated October 24, 2025, and related instruments.
Outlook, Risks, and Contingencies
Contingencies: Helena's release of claims is conditional upon the Company's satisfaction of specified release conditions outlined in the settlement documents.
Risks: The Company faces immediate and near-term cash outflows totaling $1,000,000 ($500,000 immediate + $500,000 over five months) in addition to the assignment of rights under the $2.5 million note. Failure to meet the specified release conditions could result in the reinstatement of prior claims.
Investor Verification Checklist
- Verify the Company's current cash balance to confirm the ability to fund the immediate $500,000 payment and subsequent monthly installments.
- Review the full text of the Settlement Agreement (Exhibit 10.1) to understand the specific "release conditions" required to finalize the dispute resolution.
- Assess the impact of assigning rights under the $2,500,000 promissory note on the Company's future debt obligations and balance sheet.
- Confirm whether the surrender of Series A Convertible Preferred Stock alters the Company's capital structure or dilution profile.